BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Whitehawk Therapeutics Inc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-11 7:33 pm Sale | 2021-12-31 | 13G | Whitehawk Therapeutics Inc WHWK | BIOTECHNOLOGY VALUE FUND L P | 899,392 4.300% | -247,660 (-21.59%) | Filing |
| 2021-09-07 5:26 pm Purchase | 2021-08-26 | 13G | Whitehawk Therapeutics Inc WHWK | BIOTECHNOLOGY VALUE FUND L P | 1,147,052 5.500% | 1,147,052 (New Position) | Filing |